Proton Pump Inhibitor (PPI)
Pregnancy: Compatible — omeprazole/pantoprazole data reassuring
Pantoprazole
Brand names: Protium
Adult dose
Dose: Oral: 20–40 mg OD. IV: 40 mg OD (or BD for bleeding peptic ulcer after endoscopy)
Route: Oral or IV infusion
Frequency: Once daily (oral); BD in high-risk peptic ulcer
Max: 80 mg/day
Preferred PPI with clopidogrel (less CYP2C19 interaction vs omeprazole). High-dose IV (80 mg bolus then 8 mg/h) after endoscopic haemostasis for peptic ulcer bleeding.
Paediatric dose
Route: Oral or IV
Frequency: OD
Max: 40 mg OD
Concentration: 4 mg/ml
BNF for Children: weight-banded fixed doses — ≥15 kg to <40 kg: 20 mg OD; ≥40 kg: 40 mg OD. Not recommended <5 years (limited data). Weight-based calculator not applicable. Source: BNF for Children 2024
Dose adjustments
Renal
No dose adjustment required
Hepatic
Maximum 20 mg/day in severe hepatic impairment
Clinical pearls
- Preferred PPI with clopidogrel due to less CYP2C19 inhibition — use pantoprazole not omeprazole
- Hypomagnesaemia: check Mg2+ in patients on long-term PPI, especially those also on digoxin or diuretics
- C. diff risk increases with PPI use — always review appropriateness of ongoing prescribing
- Intravenous pantoprazole used after endoscopic haemostasis to reduce re-bleeding: 80 mg loading, then 8 mg/h for 72h
Contraindications
- Concomitant rilpivirine, nelfinavir, or atazanavir (without ritonavir) — reduces antiviral absorption
Side effects
- Headache
- Diarrhoea
- Nausea
- Hypomagnesaemia (long-term use)
- C. difficile (long-term use)
- Interstitial nephritis (rare)
- Fundic gland polyps
Interactions
- Clopidogrel — less interaction than omeprazole (preferred PPI with antiplatelet therapy)
- Methotrexate — PPIs reduce methotrexate clearance (monitor toxicity)
- Antivirals (atazanavir, rilpivirine) — reduced absorption
Monitoring
- Magnesium (long-term use)
- Vitamin B12 (prolonged use)
- Symptom response
- Review ongoing indication at each encounter
Reference: BNFc; BNF; NICE CG141 Peptic Ulcer; ESC AFib PPI guidance. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- SMART Risk Score for Recurrent CVD · Cardiovascular Risk
- IABP Timing Assessment · Mechanical Circulatory Support
- PCSK9 Inhibitor Eligibility Assessment · Lipid Management
- Immune-Related Adverse Events (irAE) -- GI Toxicity Colitis Grading · Oncology-Related GI
- irAE Hepatitis Grading (CTCAE) · Immunotherapy
- DIPSS — Dynamic International Prognostic Scoring System for Myelofibrosis · Cancer Prognosis
Drugs